In vitiligo, IL-33 may be considered an alarmin; it may be released by apoptotic or necrotic keratinocytes and inhibits melanocytes growth, blocking growth factors and increasing pro-inflammatory IL-6 and TNFα expression. The gene discussed is IL33; the disease is vitiligo.